RADIAL is approved in Denmark!

Utrecht, November 2, 2022

On the 5th of September the team submitted all the necessary documents related to RADIAL for the second part of the CTIS submission and … on the 2nd of November we achieved yet another milestone as the Danish authorities have approved our study. The final preparations are now in full swing to get the last details and approvals ready and we hope to recruit our first patients before the end of the year.

We’re very excited about his and hope to share the approvals for the other countries soon.


This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 831458. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.

Notes for editors – not for publication
If you would like more information, please contact the spokesperson at the UMC Utrecht.
Joris Prinssen: +31 6 2571 0234